Optimizing post–chimeric antigen receptor (CAR) T cell monitoring: Evidence across lisocabtagene maraleucel (liso-cel) pivotal clinical trials and real-world experience.M. Kamdar, Matthew A. Lunning, Miguel-Angel Perales et al.|Journal of Clinical Oncology|2025Cited by 0
458 | OPTIMIZING POST–CHIMERIC ANTIGEN RECEPTOR T CELL MONITORING: EVIDENCE ACROSS LISOCABTAGENE MARALEUCEL PIVOTAL CLINICAL TRIALS AND REAL‐WORLD EXPERIENCEM. Kamdar, Matthew A. Lunning, M. Shadman et al.|Hematological Oncology|2025Cited by 0